Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Chase Feiger, M.D. - AI Is Rewriting How Pharma Engages Patients And Doctors
AI Is Rewriting How Pharma Engages Patients And Doctors
Forbes

Image created with DALL·E / OpenAI. For two decades, the branded pharma website has been treated as the centerpiece of digital engagement. It has been the polished ‘front door', where brands prepared to tell their story and hoped…

republicworld.com - Abhishek Tiwari - From Generics Hub To Innovation Powerhouse: The Modi Govt's Initiatives Propel India Towards Pharma Evolution
From Generics Hub To Innovation Powerhouse: The Modi Govt's Initiatives Propel India Towards Pharma Evolution
Republic World

New Delhi: The Indian pharmaceutical sector is undergoing a quiet transformation, with research and development moving from the periphery to the core of its growth strategy. From the reputation of the world's low-cost supplier of generic medicines…

thefederalist.com - Christopher Jacobs - Why Trump's Obesity Drug 'Deal' Will Help Big Pharma Most Of All
Why Trump's Obesity Drug 'Deal' Will Help Big Pharma Most Of All
The Federalist: Religion, Politics, and Culture

Should the rooster get credit for the sun rising in the morning? Hardly. Yet in recent weeks, two companies received significant financial benefits for taking actions that market forces were likely going to bring about on their own. The agreement…

undark.org - Claudia López Lloreda - Pharma Pushes Back on State PFAS Regulations
Pharma Pushes Back on State PFAS Regulations
Undark Magazine | Truth, Beauty, Science

In January 2025, Minnesota's law regulating PFAS, a class of synthetic chemicals used to make products resistant to heat, grease, oil, and water, came into effect. The statute, one of the strongest of its kind in the United States, banned the…

marketbeat.com - Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 26,156 Shares of Stock
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 26,156 Shares of Stock
MarketBeat

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 26,156 shares of the company's stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $65.84, for a total transaction of…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Sets New 52-Week High - Time to Buy?
BridgeBio Pharma (NASDAQ:BBIO) Sets New 52-Week High - Time to Buy?
MarketBeat

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report)'s stock price hit a new 52-week high on Monday. The company traded as high as $69.89 and last traded at $69.6870, with a volume of 160191 shares. The stock had previously closed at $68.11.

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Coverage Initiated at Truist Financial
Ascentage Pharma Group International (NASDAQ:AAPG) Coverage Initiated at Truist Financial
MarketBeat

Equities researchers at Truist Financial assumed coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) in a research report issued to clients and investors on Monday. The firm set a 'buy' rating on the stock. A…

marketbeat.com - Vestor Capital LLC Sells 399,100 Shares of Royalty Pharma PLC $RPRX
Vestor Capital LLC Sells 399,100 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Vestor Capital LLC lowered its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 98.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,636 shares of…

marketbeat.com - DNB Asset Management AS Increases Position in Royalty Pharma PLC $RPRX
DNB Asset Management AS Increases Position in Royalty Pharma PLC $RPRX
MarketBeat

DNB Asset Management AS boosted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 76,835 shares of the biopharmaceutical…

marketbeat.com - Horizon Kinetics Asset Management LLC Boosts Stake in Royalty Pharma PLC $RPRX
Horizon Kinetics Asset Management LLC Boosts Stake in Royalty Pharma PLC $RPRX
MarketBeat

Horizon Kinetics Asset Management LLC raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 7.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…

swissinfo.ch - swissinfo.ch - Online abuse drives young women out of Swiss politics, study finds
Online abuse drives young women out of Swiss politics, study finds
www.swissinfo.ch

According to the study, young politicians in Switzerland face online abuse at similar rates. But the nature of the hostility varies sharply depending on whether the target is a woman or a man. Women are far more likely to face attacks linked to…

marketbeat.com - Mediolanum International Funds Ltd Has $2.01 Million Stock Holdings in Royalty Pharma PLC $RPRX
Mediolanum International Funds Ltd Has $2.01 Million Stock Holdings in Royalty Pharma PLC $RPRX
MarketBeat

Mediolanum International Funds Ltd trimmed its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 57.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 56,018 shares of the…

scmp.com - Julie Zhang - Beauty market aglow: young Chinese splurge on self-care, Fosun-backed firm says
Beauty market aglow: young Chinese splurge on self-care, Fosun-backed firm says
South China Morning Post

Young Chinese consumers, including a growing number of men, are splurging on aesthetic medical treatments for physical, emotional and social wellness, according to the CEO of Fosun Pharma‑backed Sisram Medical and its subsidiary Alma, who…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0803 GMT – CSPC Pharmaceutical Group's growth visibility for next year appears clouded to UOB Kay Hian…

the-sun.com - Jeylin Mehmet - J-Lo 'is paid $2m' to perform at Indian billionaire's ultra-lavish wedding
J-Lo 'is paid $2m' to perform at Indian billionaire's ultra-lavish wedding
The US Sun

JENNIFER Lopez pocketed a staggering $2 million to perform at a millionaire heir's jaw-dropping wedding in India. Lopez, 56, jetted to Udaipur over the weekend to headline the four-day festivities celebrating the marriage of billionaire heiress…

Receive a Daily briefing on Pharma Industry News

Get Started